Sei Investments CO Grifols Sa Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Grifols Sa stock. As of the latest transaction made, Sei Investments CO holds 2,169,961 shares of GRFS stock, worth $17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,169,961

Previous 2,209,547 1.79%

Holding current value

$17 Million

Previous $13.9 Million 38.43%

% of portfolio

0.03%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$6.28 - $9.38 $248,600 - $371,316	-39,586 Reduced 1.79%	2,169,961 $19.3 Million
Q2 2024 Aug 13, 2024	BUY	$6.27 - $7.7 $627,821 - $771,008	100,131 Added 4.75%	2,209,547 $13.9 Million
Q1 2024 May 07, 2024	BUY	$5.47 - $11.38 $585,290 - $1.22 Million	107,000 Added 5.34%	2,109,416 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $3,099 - $4,647	-402 Reduced 0.02%	2,002,416 $23.1 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $11.6 Million - $14.2 Million	1,300,978 Added 185.37%	2,002,818 $18.3 Million
Q2 2023 Aug 11, 2023	BUY	$7.14 - $9.29 $2.83 Million - $3.68 Million	396,600 Added 129.93%	701,840 $6.43 Million
Q1 2023 May 12, 2023	BUY	$6.65 - $10.69 $159,600 - $256,560	24,000 Added 8.53%	305,240 $2.25 Million
Q4 2022 Feb 10, 2023	SELL	$5.96 - $8.53 $1.55 Million - $2.23 Million	-260,860 Reduced 48.12%	281,240 $2.39 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $232 - $557	-39 Reduced 0.01%	542,100 $3.34 Million
Q1 2022 May 13, 2022	BUY	$10.37 - $12.73 $742,533 - $911,518	71,604 Added 15.22%	542,139 $6.33 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $623,187 - $932,034	61,037 Added 14.91%	470,535 $5.28 Million
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $362,991 - $446,322	25,799 Added 6.72%	409,498 $5.98 Million
Q2 2021 Aug 06, 2021	BUY	$16.62 - $18.94 $1,745 - $1,988	105 Added 0.03%	383,699 $6.66 Million
Q1 2021 May 12, 2021	BUY	$15.15 - $19.78 $1.47 Million - $1.92 Million	97,283 Added 33.98%	383,594 $6.64 Million
Q4 2020 Feb 08, 2021	BUY	$16.86 - $19.67 $2.73 Million - $3.18 Million	161,783 Added 129.92%	286,311 $5.28 Million
Q3 2020 Dec 04, 2020	SELL	$15.4 - $20.16 $28,197 - $36,912	-1,831 Reduced 1.45%	124,528 $2.16 Million
Q3 2020 Nov 06, 2020	SELL	$15.4 - $20.16 $4.38 Million - $5.73 Million	-284,211 Reduced 69.22%	126,359 $2.19 Million
Q2 2020 Aug 17, 2020	BUY	$18.24 - $21.45 $4.94 Million - $5.81 Million	270,831 Added 193.81%	410,570 $7.49 Million
Q2 2020 Aug 11, 2020	SELL	$18.24 - $21.45 $321,680 - $378,292	-17,636 Reduced 11.21%	139,739 $3.25 Million
Q1 2020 May 14, 2020	BUY	$16.28 - $25.63 $299,698 - $471,822	18,409 Added 13.25%	157,375 $3.17 Million
Q4 2019 Feb 06, 2020	BUY	$19.57 - $23.52 $195 - $235	10 Added 0.01%	138,966 $3.24 Million
Q3 2019 Nov 12, 2019	SELL	$19.85 - $22.76 $100,341 - $115,051	-5,055 Reduced 3.51%	138,956 $2.79 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $322,055 - $386,319	18,309 Added 14.57%	144,011 $3.04 Million
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $663,092 - $740,409	36,818 Added 41.42%	125,702 $2.53 Million
Q4 2018 Feb 13, 2019	SELL	$17.44 - $21.53 $592 - $732	-34 Reduced 0.04%	88,884 $1.9 Million
Q3 2018 Nov 08, 2018	SELL	$19.97 - $21.96 $16,395 - $18,029	-821 Reduced 0.91%	88,918 $1.9 Million
Q2 2018 Aug 03, 2018	SELL	$20.16 - $24.68 $3.1 Million - $3.8 Million	-153,869 Reduced 63.16%	89,739 $1.93 Million
Q1 2018 May 11, 2018	SELL	$20.31 - $24.95 $4.74 Million - $5.83 Million	-233,484 Reduced 48.94%	243,608 $5.17 Million
Q4 2017 Feb 08, 2018	SELL	$20.99 - $23.89 $1.47 Million - $1.68 Million	-70,244 Reduced 12.83%	477,092 $10.9 Million
Q3 2017 Nov 06, 2017	BUY	$20.07 - $21.89 $11 Million - $12 Million	547,336	547,336 $12 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Grifols Sa Transaction History